Recent Finacing
Recent Raise
Auxilius Pharma develops value-added cardiovascular medicines, advancing AUX-001, a once-daily dual-mechanism anti-anginal aimed at treating chronic-stable angina and improving disease outcomes.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Auxilius Pharma.
